- Home
- ATXS vs MOV Comparison
ATXS vs MOV Comparison
Compare ATXS & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- MOV
- Stock Information
- Founded
- ATXS 2008
- MOV 1961
- Country
- ATXS United States
- MOV United States
- Employees
- ATXS N/A
- MOV N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- MOV Consumer Specialties
- Sector
- ATXS Health Care
- MOV Consumer Discretionary
- Exchange
- ATXS Nasdaq
- MOV Nasdaq
- Market Cap
- ATXS 516.4M
- MOV 441.7M
- IPO Year
- ATXS 2015
- MOV 1993
- Fundamental
- Price
- ATXS $7.50
- MOV $19.14
- Analyst Decision
- ATXS Strong Buy
- MOV Strong Buy
- Analyst Count
- ATXS 5
- MOV 2
- Target Price
- ATXS $25.60
- MOV $36.25
- AVG Volume (30 Days)
- ATXS 368.6K
- MOV 131.3K
- Earning Date
- ATXS 03-03-2025
- MOV 12-05-2024
- Dividend Yield
- ATXS N/A
- MOV 7.32%
- EPS Growth
- ATXS N/A
- MOV N/A
- EPS
- ATXS N/A
- MOV 1.05
- Revenue
- ATXS N/A
- MOV $658,329,000.00
- Revenue This Year
- ATXS N/A
- MOV N/A
- Revenue Next Year
- ATXS N/A
- MOV $4.31
- P/E Ratio
- ATXS N/A
- MOV $18.21
- Revenue Growth
- ATXS N/A
- MOV N/A
- 52 Week Low
- ATXS $6.96
- MOV $17.86
- 52 Week High
- ATXS $16.90
- MOV $29.45
- Technical
- Relative Strength Index (RSI)
- ATXS 29.58
- MOV 42.47
- Support Level
- ATXS $7.29
- MOV $18.56
- Resistance Level
- ATXS $7.95
- MOV $19.54
- Average True Range (ATR)
- ATXS 0.42
- MOV 0.55
- MACD
- ATXS -0.08
- MOV -0.08
- Stochastic Oscillator
- ATXS 15.25
- MOV 32.67
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.